paclitaxel/edema

Veza se sprema u međuspremnik

Odaberite vrstu sortiranja

Stranica 1 iz 165 rezultatima

Multimodal imaging in paclitaxel-induced macular edema: the microtubule disfunction.

Samo registrirani korisnici mogu prevoditi članke

Prijava Registriraj se

Taxanes are a rare cause of macular edema. A 63-year-old female, under paclitaxel treatment, was observed with progressively bilateral visual acuity loss and an apparently normal fundus. Optical coherence tomography revealed a bilateral cystoid macular edema with a late petaloid pooling on

A case of cystoid macular edema associated with Paclitaxel chemotherapy.

Samo registrirani korisnici mogu prevoditi članke

Prijava Registriraj se

We encountered a patient with cystoid macular edema (CME) secondary to paclitaxel use. A 57-year-old man presented with gradual decreased bilateral vision. His chemotherapeutic regimen consisted of bevacizumab, paclitaxel (175 mg/m(2) for 5 months), and carboplatin. Optical coherence tomography

Indocyanine green angiography findings of cystoid macular edema secondary to paclitaxel therapy.

Samo registrirani korisnici mogu prevoditi članke

Prijava Registriraj se

OBJECTIVE To report 2 cases of paclitaxel-related maculopathy manifesting as cystoid macular edema (CME) with late petaloid hyperfluorescence on indocyanine green angiography (IA). METHODS A 74-year-old man (patient 1) undergoing paclitaxel chemotherapy for gastric and metastatic liver cancer and a

Cystoid macular edema and macular pigmentation associated with nab-Paclitaxel therapy.

Samo registrirani korisnici mogu prevoditi članke

Prijava Registriraj se

OBJECTIVE To report the first known case of retinal pigment epithelium hyperpigmentation changes and cystoid macular edema in a patient on nab-paclitaxel therapy. METHODS Observational case report. RESULTS A 72-year-old man on nab-paclitaxel therapy for non-small cell lung carcinoma developed

Bilateral Cystoid Macular Edema Secondary to Paclitaxel Treatment.

Samo registrirani korisnici mogu prevoditi članke

Prijava Registriraj se

Cystoid macular edema is rarely observed secondary to paclitaxel treatment. A 55-year-old female patient was applied five cures of paclitaxel and carboplatin chemotherapy after being diagnosed with metastatic ovarian cancer. The patient had a normal bilateral vision prior to the chemotherapy

Cystoid macular edema secondary to Paclitaxel (abraxane).

Samo registrirani korisnici mogu prevoditi članke

Prijava Registriraj se

OBJECTIVE To report a case of cystoid macular edema secondary to systemic paclitaxel. METHODS A 58-year-old man with Stage 4 metastatic cutaneous melanoma presented with decreased vision and macular edema while having minimal fluorescein leakage 7 months into a course of paclitaxel chemotherapy. The

Dexamethasone intravitreal implant in cystoid macular edema secondary to paclitaxel therapy.

Samo registrirani korisnici mogu prevoditi članke

Prijava Registriraj se

To report the first case of cystoid macular edema (CME) induced by nabpaclitaxel treated with intravitreal dexamethasone implant.A 67 year-old man diagnosed with unresectable pancreatic cancer presented with decreased vision in both eyes while receiving

Cystoid macular edema without leakage secondary to nab-Paclitaxel (Abraxane): clinical experience with intravitreal bevacizumab.

Samo registrirani korisnici mogu prevoditi članke

Prijava Registriraj se

OBJECTIVE Cystoid macular edema (CME) is a rarely reported side effect of nanoparticle albumin bound (nab)-paclitaxel therapy-an antimitotic agent used for breast cancer. We describe a patient with bilateral CME secondary to Abraxane that was minimally responsive to intravitreal bevacizumab. To our

Cystoid macular edema secondary to nanoparticle albumin-bound Paclitaxel therapy.

Samo registrirani korisnici mogu prevoditi članke

Prijava Registriraj se

The authors report a case of nanoparticle albumin-bound paclitaxel-induced cystoid macular edema (CME) without fluorescein angiographic leakage in a patient being treated for metastatic breast cancer. The CME briskly improved 3 weeks after the chemotherapeutic agent was discontinued and was

Nab-paclitaxel-induced cystoid macular edema in a patient with pre-existing optic neuropathy.

Samo registrirani korisnici mogu prevoditi članke

Prijava Registriraj se

Paclitaxel is a widely used chemotherapy agent that has rarely been associated with ophthalmic toxicities. Cystoid macular edema is one such rare side effect of paclitaxel therapy. Its pathophysiology remains poorly understood. Here, we report on a 69-year-old woman who developed cystoid macular

Effects of the taxanes paclitaxel and docetaxel on edema formation and interstitial fluid pressure.

Samo registrirani korisnici mogu prevoditi članke

Prijava Registriraj se

Interstitial fluid pressure (P(if)) is important for maintaining constant interstitial fluid volume. In several acute inflammatory reactions, a dramatic lowering of P(if) has been observed, increasing transcapillary filtration pressure and favoring initial and rapid edema formation. This lowering of

[A Case of Cystoid Macular Edema Secondary to Albumin-Bound Paclitaxel Therapy].

Samo registrirani korisnici mogu prevoditi članke

Prijava Registriraj se

A 73-year-old woman diagnosed with unresectable pancreatic cancer received weekly gemcitabine(GEM)plus albuminbound paclitaxel(nab-PTX)therapy. Four months after nab-PTX therapy was initiated, she presented with a rapidly decreasing vision in her left eye at an ophthalmology clinic. On admission,

Cystoid macular edema induced by nab-paclitaxel.

Samo registrirani korisnici mogu prevoditi članke

Prijava Registriraj se

Cystoid macular edema (CME) is a rare complication of taxane-based chemotherapy. We encountered a patient who developed CME during treatment with nab-paclitaxel for metastatic breast cancer. Early detection of this disease enables continuation of appropriate treatment without reducing the quality of

Sub-Tenon Injections of Triamcinolone Acetonide Had Limited Effect on Cystoid Macular Edema Secondary to Nanoparticle Albumin-Bound-Paclitaxel (Abraxane).

Samo registrirani korisnici mogu prevoditi članke

Prijava Registriraj se

Purpose. To report the first case of cystoid macular edema (CME) induced by nanoparticle albumin-bound- (nab-) paclitaxel treated with sub-Tenon injections of triamcinolone acetonide (STTA) with detailed long-term follow-up. Case. A 39-year-old Japanese woman with breast cancer presents with

POSSIBLE EFFICACY OF TOPICAL DORZOLAMIDE IN THE TREATMENT OF PACLITAXEL-RELATED CYSTOID MACULAR EDEMA.

Samo registrirani korisnici mogu prevoditi članke

Prijava Registriraj se

OBJECTIVE Paclitaxel (Taxol) is a microtubule-stabilizing agent and belongs to the taxane group of chemotherapeutic drugs. It is used to treat numerous malignancies, such as breast and lung cancers. A rare side effect of this drug includes cystoid macular edema (CME), which is presumed to resolve

Prethodni
1
2
3
4
5
6
...
10
11
Sljedeći

Pridružite se našoj
facebook stranici

Herbal & Natural Medicine

Najkompletnija baza ljekovitog bilja potpomognuta znanošću

Radi na 55 jezika
Biljni lijekovi potpomognuti znanošću
Prepoznavanje bilja slikom
Interaktivna GPS karta - označite bilje na mjestu (uskoro)
Pročitajte znanstvene publikacije povezane s vašom pretragom
Pretražite ljekovito bilje po učincima
Organizirajte svoje interese i budite u toku s istraživanjem vijesti, kliničkim ispitivanjima i patentima

Upišite simptom ili bolest i pročitajte o biljkama koje bi mogle pomoći, unesite travu i pogledajte bolesti i simptome protiv kojih se koristi.
* Svi podaci temelje se na objavljenim znanstvenim istraživanjima